Adam R Craig is President and CEO of CTI BIOPHARMA CORP. Currently has a direct ownership of 0 shares of CTIC, which is worth approximately $0. The most recent transaction as insider was on Jun 03, 2022, when has been sold 18,223 shares (Common Stock) at a price of $0.84 per share, resulting in proceeds of $15,307. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Adam R Craig Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 03 2022
BUY
Exercise of conversion of derivative security
$15,307 $0.84 p/Share
18,223 Added 34.3%
34,901 Common Stock
Jun 02 2022
SELL
Open market or private sale
$162,000 $6.0 p/Share
27,000 Reduced 61.82%
16,678 Common Stock
Jun 02 2022
BUY
Exercise of conversion of derivative security
$22,680 $0.84 p/Share
27,000 Added 38.2%
43,678 Common Stock
Jun 01 2022
SELL
Open market or private sale
$162,000 $6.0 p/Share
27,000 Reduced 61.82%
16,678 Common Stock
Jun 01 2022
BUY
Exercise of conversion of derivative security
$22,680 $0.84 p/Share
27,000 Added 38.2%
43,678 Common Stock
Dec 31 2021
BUY
Grant, award, or other acquisition
$6,706 $2.11 p/Share
3,178 Added 16.01%
16,678 Common Stock
Dec 02 2021
BUY
Open market or private purchase
$5,320 $1.52 p/Share
3,500 Added 20.59%
13,500 Common Stock
Jun 30 2021
BUY
Grant, award, or other acquisition
$10,600 $2.12 p/Share
5,000 Added 33.33%
10,000 Common Stock
Jul 01 2020
BUY
Grant, award, or other acquisition
$4,900 $0.98 p/Share
5,000 Added 50.0%
5,000 Common Stock
ARC

Adam R Craig

President and CEO
Seattle, WA

Track Institutional and Insider Activities on CTIC

Follow CTI BIOPHARMA CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTIC shares.

Notify only if

Insider Trading

Get notified when an Cti Biopharma Corp insider buys or sells CTIC shares.

Notify only if

News

Receive news related to CTI BIOPHARMA CORP

Track Activities on CTIC